Rolapitant Hydrochloride

Pronunciation

The hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with potential antiemetic activity. Upon oral administration, rolapitant competitively binds to and blocks the activity of the NK1-receptor in the central nervous system, by inhibiting the binding of the endogenous ligand, substance P (SP). This may prevent both SP-induced emesis and chemotherapy-induced nausea and vomiting (CINV). The interaction of SP with the NK1-receptor plays a key role in the induction of nausea and vomiting caused by emetogenic cancer chemotherapy. Compared to other NK1-receptor antagonists, rolapitant has both a more rapid onset of action and a much longer half-life. (NCI Thesaurus)

YOU MAY ALSO LIKE

Roland Morris Disability Questionnaire

A standardized survey developed by M.O. Roland and R.W. Morris in 1983 used to assess the level of disability experienced by a…

Rogletimide

An orally active aminoglutethimide derivative with potential antineoplastic activity. Rogletimide reversibly inhibits the activity of aromatase, a cytochrome P450 family enzyme found…

Roflumilast

An orally available, long-acting inhibitor of phosphodiesterase (PDE) type 4 (PDE4), with anti-inflammatory and potential antineoplastic activities. Upon administration, roflumilast and its…

Rofecoxib

A drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent…

Roentgen

A unit of exposure to ionizing radiation in CGS system. One roentgen is the amount of gamma or x-rays required to produce…

Rodorubicin

A synthetic tetraglycosidic anthracycline antibiotic with antineoplastic activity. Rodorubicin appears to intercalate DNA and causes cell death. Due to its severe cardiotoxic…